Measuring Binaural Temporal-Fine-Structure Sensitivity in Hearing-Impaired Listeners, Using the TFS-AF Test.


Journal

Journal of the American Academy of Audiology
ISSN: 2157-3107
Titre abrégé: J Am Acad Audiol
Pays: United States
ID NLM: 9114646

Informations de publication

Date de publication:
02 2020
Historique:
pubmed: 27 6 2019
medline: 8 7 2021
entrez: 27 6 2019
Statut: ppublish

Résumé

Various methods have been used to measure temporal-fine-structure (TFS) sensitivity in hearing-impaired (HI) listeners. A new method called TFS-adaptive frequency (TFS-AF) test, tracks the highest frequency up to which a person can detect a given interaural phase difference (IPD) in bursts of pure tones. So far, the test was only administered to listeners with normal hearing (NH) or impaired low-frequency hearing. It is currently not known if this test can also be used for listeners with different configurations of hearing losses. To investigate whether the TFS-AF test can also be used on listeners with a larger diversity of hearing losses and what would be the best fixed IPD value to conduct the test. Using a cross-sectional study design, we compared the thresholds of TFS-AF test between the NH and HI listeners at three different IPDs (90°, 60°, and 30°). Thirty NH (mean age = 37.9; range 19-53 years) and thirty HI (mean age = 38.6; range 19-53 years) with different configurations of hearing losses were tested. The listeners were able to complete the TFS-AF test at larger values of IPD. Average thresholds were lower (i.e., worse) in the HI listeners than in the NH listeners. Threshold did not correlate with the listeners' age in each group. This test can be used clinically as it provides a graded measure of TFS ability for young to young-old adult listeners with a variety of hearing losses.

Sections du résumé

BACKGROUND
Various methods have been used to measure temporal-fine-structure (TFS) sensitivity in hearing-impaired (HI) listeners. A new method called TFS-adaptive frequency (TFS-AF) test, tracks the highest frequency up to which a person can detect a given interaural phase difference (IPD) in bursts of pure tones. So far, the test was only administered to listeners with normal hearing (NH) or impaired low-frequency hearing. It is currently not known if this test can also be used for listeners with different configurations of hearing losses.
PURPOSE
To investigate whether the TFS-AF test can also be used on listeners with a larger diversity of hearing losses and what would be the best fixed IPD value to conduct the test.
RESEARCH DESIGN
Using a cross-sectional study design, we compared the thresholds of TFS-AF test between the NH and HI listeners at three different IPDs (90°, 60°, and 30°).
STUDY SAMPLE
Thirty NH (mean age = 37.9; range 19-53 years) and thirty HI (mean age = 38.6; range 19-53 years) with different configurations of hearing losses were tested.
RESULTS
The listeners were able to complete the TFS-AF test at larger values of IPD. Average thresholds were lower (i.e., worse) in the HI listeners than in the NH listeners. Threshold did not correlate with the listeners' age in each group.
CONCLUSION
This test can be used clinically as it provides a graded measure of TFS ability for young to young-old adult listeners with a variety of hearing losses.

Identifiants

pubmed: 31241450
doi: 10.3766/jaaa.18068
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

105-110

Informations de copyright

American Academy of Audiology.

Auteurs

Deena Susan Mathew (DS)

Jawaharlal Institute of Postgraduate Medical Education and Research, Pondicherry, India.

Anuprasad Sreenivasan (A)

Jawaharlal Institute of Postgraduate Medical Education and Research, Pondicherry, India.

Arun Alexander (A)

Jawaharlal Institute of Postgraduate Medical Education and Research, Pondicherry, India.

Saravanan Palani (S)

Jawaharlal Institute of Postgraduate Medical Education and Research, Pondicherry, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH